Faced with a another wave of infections, Europe is again struggling to get a grip on the Covid-19 pandemic. At the moment, the efforts of containing the virus currently focus on getting as many people vaccinated as possible as quickly as possible. And Eastern Partnership countries are no exception to that rule. But while the EU works around the clock to register and deliver the vaccines produced by six Western companies, neither the Chinese (Sinovac Biotech) nor the Russian vaccine (Sputnik-V) are on the European officials' immunisation menu. And that may be a luxury most Eastern Partnership countries currently can’t afford.
Some, like the political elites in Georgia, Moldova and Ukraine, do criticise the Russian cure. They are suspicious of Sputnik-V for both its alleged inefficiency and the propaganda campaign pursued by Russian foreign policy. The memory of the 2020 disinformation campaigns while supposedly aiding Italy or Serbia are still fresh.
However, the refusal of even examining the possibility of importing the Sputnik-V has fuelled the internal animosities between government and the pro-Russian opposition in Ukraine. The country’s Minister of Foreign Affairs Dmitry Kuleba highlighted the propagandistic costs that come with the Russian vaccine. China’s propaganda however isn’t bothering Kyiv, which is willing to purchase the Chinese vaccine as well as Western ones.
In Belarus and Armenia, on the other hand, there’s hardly any scepticism towards the Russian vaccine and already arranged the imports or are in advanced bilateral negotiations. And across the region, there’s less scepticism towards China. The latter seems to act much more subtly, raising minimum noise and negative perceptions for its anti-Covid-19 cure. As long as Eastern Partnership countries cannot receive the vaccine from Western pharmaceutical companies, they will be signing up for the Chinese vaccine, if not the Russian one.
Read more at:
The EU's vaccine 'non-diplomacy' – International relations | IPS Journal
No comments:
Post a Comment